The AeroPace® System is approved by the United States Food and Drug Administration to improve weaning success in adult patients on mechanical ventilation at least 96 hours and who have not weaned. The AeroPace System is not approved in any other country.
The AeroNova® System is limited by Federal Law (United States)to investigational use. Used exclusively for clinical investigations.
Lungpacer is developing innovative new technologies. By visiting Lungpacer Medical’s website, you acknowledge that not all the technology cited has regulatory approval and clinical trials are ongoing for investigational devices. These clinical studies may show an increased benefit, no benefit, or an adverse benefit to the patient.
By visiting the Lungpacer Medical website, you acknowledge that you have read and understand the terms of our
Privacy Policy.
Our site also uses cookies to help us deliver services. By using Lungpacer services,
you agree to the
Terms of Use.
ACCEPT
